Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mattsson

Showing results (41-50 of 145) with videos related to

Pageof 15
Sort By:
Leukemia|December 26, 2001
Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantationJ Mattsson, M Uzunel, L Tammik, et al.
Bone Marrow Transplantation|September 1, 2009
Sequential Organ Failure Assessment predicts the outcome of SCT recipients admitted to intensive care unitK Gilli, M Remberger, H Hjelmqvist, et al.
Plant Molecular Biology|March 1, 1992
A new homeobox-leucine zipper gene from Arabidopsis thalianaJ Mattsson, E Söderman, M Svenson, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 31, 2013
Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantationsO Blennow, P Ljungman, E Sparrelid, et al.
Neurotoxicology|January 5, 2002
Risk assessment under FQPA: case study with chlorpyrifosC B Clevelan, G R Oliver, B Chen, et al.
Blood|September 6, 2001
The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemiaM Uzunel, J Mattsson, M Jaksch, et al.
Bone Marrow Transplantation|March 5, 2008
No impact of NOD2/CARD15 on outcome after SCTD Sairafi, M Uzunel, M Remberger, et al.
Bone Marrow Transplantation|July 5, 2006
Myeloablative conditioning for hematopoietic stem-cell transplantation in patients with non-malignant diseasesO Ringdén, P Svenberg, K Le Blanc, et al.
European Journal of Cancer Care|November 19, 2016
Family members' life situation and experiences of different caring organisations during allogeneic haematopoietic stem cells transplantation-A qualitative studyK Bergkvist, J Larsen, U-B Johansson, et al.
Clinical and Experimental Immunology|September 17, 2003
Memory B lymphocytes determine repertoire oligoclonality early after haematopoietic stem cell transplantationB Omazic, I Lundkvist, J Mattsson, et al.
Pageof 15

Showing results (41-50 of 145) with videos related to

Sort By:
Pageof 15
Leukemia|December 26, 2001
Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantationJ Mattsson, M Uzunel, L Tammik, et al.
Bone Marrow Transplantation|September 1, 2009
Sequential Organ Failure Assessment predicts the outcome of SCT recipients admitted to intensive care unitK Gilli, M Remberger, H Hjelmqvist, et al.
Plant Molecular Biology|March 1, 1992
A new homeobox-leucine zipper gene from Arabidopsis thalianaJ Mattsson, E Söderman, M Svenson, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 31, 2013
Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantationsO Blennow, P Ljungman, E Sparrelid, et al.
Neurotoxicology|January 5, 2002
Risk assessment under FQPA: case study with chlorpyrifosC B Clevelan, G R Oliver, B Chen, et al.
Blood|September 6, 2001
The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemiaM Uzunel, J Mattsson, M Jaksch, et al.
Bone Marrow Transplantation|March 5, 2008
No impact of NOD2/CARD15 on outcome after SCTD Sairafi, M Uzunel, M Remberger, et al.
Bone Marrow Transplantation|July 5, 2006
Myeloablative conditioning for hematopoietic stem-cell transplantation in patients with non-malignant diseasesO Ringdén, P Svenberg, K Le Blanc, et al.
European Journal of Cancer Care|November 19, 2016
Family members' life situation and experiences of different caring organisations during allogeneic haematopoietic stem cells transplantation-A qualitative studyK Bergkvist, J Larsen, U-B Johansson, et al.
Clinical and Experimental Immunology|September 17, 2003
Memory B lymphocytes determine repertoire oligoclonality early after haematopoietic stem cell transplantationB Omazic, I Lundkvist, J Mattsson, et al.
Pageof 15